- First-line treatment for Heart Failure (CHF). ( pg 250-254, 273)
- Treatment of acute heart failure and pulmonary edema. ( pg 250-254, 25, 37, 249)
- Side effects of ACE inhibitors and mechanism of action of ACE inhibitors. (pg. 279, 274-275)
- Which antihypertensive medication classes are contraindicated in patients with asthma. (pg. 261)
- Mechanism of action of Digoxin. ( pg 248-255, 274t)
- Uses and the mechanism of action of Penicillin. (pg. 672-673, 674)
- Uses, mechanism of action, and side effects of Beta Blockers. (pg. 256-258, 256-264)
- Uses, mechanism of action, and side effects of Tetracyclines. ( pg. 683-686, 685b)
- Usage of antiarrhythmics, their mechanisms of action, and side effects of antiarrhythmic agents.
- Treatment of Parkinson’s disease ( 506-508, 506t)
- First line treatment of depression. ( pg. 519)
- Preferred antidepressants used in the elderly (less anticholgenic effects) ( pg.522)
- Adverse effects associated with SSRIs (pg. 519)
- Medications used to treat depression: including SSRIs, SNRIs, DNRIs, etc. ( 517, 526-527, 517t, 530)
- SSRIs can be used in children ( pg. 528)
- First line treatment(s) for Alzheimer’s Disease (pg. 458-460)
- First-line treatment for generalized seizure management (pg. 491-496)
- Side effects of Carbamazepine and its lab monitoring ( pg.497 & 500) seizures and decrease mania
- Which common drugs require serum level monitoring (pg. 47)
- Role of the NP in practice and what guides NP practice. ( pg. 10-12)
- Mechanism of action for oral contraceptives and contraindications of oral contraceptives. ( pg. 612, 609, 623)
- Mechanism(s) of action of antiprotozoal agents ( pg. 741-742)
- Antifungal medications, and which antifungals treat different diseases and fungal infections ( pg. 716)
- Contraindications when prescribing contraceptive management (refer to #21) ( pg. 617-624, 623, 624)
- Treatment(s) for Generalized Anxiety Disorder (pg 540)
- Treatment(s) for ADHD and its monitoring ( pg. 450-452)
- Role of the Drug Enforcement Administration ( pg 7, 12-13, 17, 9, 112-113)
- Treatment(s) for GERD (pg 328-331)
Instituition / Term | |
Term | Summer 2018 |
Institution | Chamberlain |
Contributor | Richard |